Min Zhao

Correlation Analysis of Pyroptosis‐Related Genes CASP1, NLRP3, AIM2, and NLRP1 With Lung Adenocarcinoma

Small intestinal metastasis in a lung adenocarcinoma patient with concurrent EML4-ALK V3 and TP53 mutations after distinct responses to tyrosine kinase inhibitors: A case report

Befotertinib for patients with pretreated EGFR T790M mutated locally advanced or metastatic NSCLC: Final overall survival results from a phase 2 trial

Treatment-related pneumonitis after thoracic radiotherapy/chemoradiotherapy combined with anti-PD-1 monoclonal antibodies in advanced esophageal squamous cell carcinoma

Efficacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy: A Phase 2, Multicenter, Single-Arm, Open-Label Study

Efficacy and safety of MIL60 compared with bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer: a phase 3 randomized, double-blind study

The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of <i>Candida albicans</i> as well as regulatory role of <i>SAP2</i> and <i>ERG11</i>

Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study

Clinicopathological characteristics and prognosis of brain metastases in elderly patients with esophageal carcinoma

Clinicopathological Features and Prognoses in Patients With Brain Metastases From Small-Cell Esophageal Carcinoma: A Retrospective Analysis of 18 Patients

Routine-Dose and High-Dose Icotinib in Patients with Advanced Non–Small Cell Lung Cancer Harboring EGFR Exon 21-L858R Mutation: the Randomized, Phase II, INCREASE Trial

Molecular characterization and prognostic analysis of non-small cell lung cancer: A single centric real-world study.

Comprehensive next-generation sequencing to portray distinctive molecular characteristics of hypermutant lung cancer.